Cutaneous leishmaniasis [proceedings].
D000965:Antimony / Q000627:therapeutic use; D000967:Antimony Sodium Gluconate / Q000627:therapeutic use; D006801:Humans; D007896:Leishmaniasis / Q000188:drug therapy; D007897:Leishmaniasis, Mucocutaneous / Q000188:drug therapy; D008795:Metronidazole / Q000627:therapeutic use; D010419:Pentamidine / Q000627:therapeutic use
D008795:Metronidazole; D010419:Pentamidine; D000965:Antimony; D000967:Antimony Sodium Gluconate